The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Propranolol Azure 40 mg film-coated tablets



Azure Pharmaceuticals LtdPA22871/031/002

Main Information

Trade NamePropranolol Azure 40 mg film-coated tablets
Active SubstancesPropranolol hydrochloride
Dosage FormFilm-coated tablet
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/031/002

Group Information

ATC CodeC07AA05 propranolol

Status

License statusAuthorised
Licence Issued08/12/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back